Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Nov 10, 2025
Open Peer Review Period: Nov 17, 2025 - Jan 12, 2026
Date Accepted: May 19, 2026
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Predicting Overall Survival in Patients With Multiple Primary Lung Cancer: Nomogram Development and Validation Study

Luo W, Rao K, Chen H, Hu C, Liu S, Wang J, Zhang D, Chen L

Predicting Overall Survival in Patients With Multiple Primary Lung Cancer: Nomogram Development and Validation Study

JMIR Cancer 2026;12:e87275

DOI: 10.2196/87275

PMID: 42361328

Predicting Overall Survival in Patients with Multiple Primary Lung Cancer: Nomogram Development and Validation Study

  • Wenzhi Luo; 
  • Kengliang Rao; 
  • Hongjia Chen; 
  • Cailian Hu; 
  • Shengming Liu; 
  • Jing Wang; 
  • Dongdong Zhang; 
  • Li Chen

ABSTRACT

Background:

With the rapid development of medical technology and the emphasis on early lung cancer screening, the incidence of multiple primary lung cancer (MPLC) has increased in recent years. However, the prognostic determinants and clinical characteristics of MPLC patients remain poorly characterized.

Objective:

This study aimed to develop and validate a nomogram for predicting overall survival (OS) in MPLC patients using data from the Surveillance, Epidemiology, and End Results (SEER) database.

Methods:

This study was reported in accordance with the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) guideline. A cohort of 4,177 MPLC patients (2007–2015) was collected from the Surveillance, Epidemiology and End Results (SEER) database. The patients were randomly divided into training (n=2,923) and validation (n=1,254) cohorts at a 7:3 ratio. Backward stepwise Cox regression identified 11 independent risk factors, which were integrated into a nomogram predicting 3-, 5-, and 8-year OS rates.

Results:

The nomogram demonstrated superior discriminative ability compared to the AJCC staging system, with higher AUC values for 3-/5-/8-year overall survival (OS) predictions in both cohorts (training cohort: 0.743, 0.751, 0.759; validation cohort: 0.737, 0.734, 0.695). Calibration curves and decision curve analysis confirmed its clinical utility.

Conclusions:

This study establishes a validated nomogram incorporating clinical and socioeconomic variables to optimize prognostic assessment and personalized treatment planning for MPLC patients.


 Citation

Please cite as:

Luo W, Rao K, Chen H, Hu C, Liu S, Wang J, Zhang D, Chen L

Predicting Overall Survival in Patients With Multiple Primary Lung Cancer: Nomogram Development and Validation Study

JMIR Cancer 2026;12:e87275

DOI: 10.2196/87275

PMID: 42361328

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.